Department of Clinical Psychiatry, University Hospital of Besançon, 25030 Besançon, France ; EA 481 Neuroscience, IFR 133, University of Franche-Comte, 25030 Besançon, France.
Biomed Res Int. 2013;2013:158746. doi: 10.1155/2013/158746. Epub 2013 Oct 30.
Psychomotor retardation is a central feature of depression which includes motor and cognitive impairments. Effective management may be useful to improve the classification of depressive subtypes and treatment selection, as well as prediction of outcome in patients with depression. The aim of this paper was to review the current status of knowledge regarding psychomotor retardation in depression, in order to clarify its role in the diagnostic management of mood disorders. Retardation modifies all the actions of the individual, including motility, mental activity, and speech. Objective assessments can highlight the diagnostic importance of psychomotor retardation, especially in melancholic and bipolar depression. Psychomotor retardation is also related to depression severity and therapeutic change and could be considered a good criterion for the prediction of therapeutic effect. The neurobiological process underlying the inhibition of activity includes functional deficits in the prefrontal cortex and abnormalities in dopamine neurotransmission. Future investigations of psychomotor retardation should help improve the understanding of the pathophysiological mechanisms underlying mood disorders and contribute to improving their therapeutic management.
精神运动阻滞是抑郁症的一个核心特征,包括运动和认知障碍。有效的管理可能有助于改善抑郁症亚型的分类和治疗选择,以及预测抑郁症患者的预后。本文旨在回顾目前关于抑郁症中精神运动阻滞的知识状况,以阐明其在情绪障碍诊断管理中的作用。阻滞改变了个体的所有行为,包括运动、精神活动和言语。客观评估可以突出精神运动阻滞的诊断重要性,尤其是在单相抑郁和双相抑郁中。精神运动阻滞也与抑郁严重程度和治疗变化有关,可被视为预测治疗效果的一个良好标准。活动抑制的神经生物学过程包括前额叶皮层的功能缺陷和多巴胺神经传递的异常。对精神运动阻滞的未来研究将有助于加深对情绪障碍发病机制的理解,并有助于改善其治疗管理。